104 related articles for article (PubMed ID: 21802166)
1. Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
Biton A; Ansorge S; Bank U; Täger M; Reinhold D; Brocke S
Immunobiology; 2011 Dec; 216(12):1295-301. PubMed ID: 21802166
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346
[TBL] [Abstract][Full Text] [Related]
3. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses.
Reinhold D; Biton A; Goihl A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
Ann N Y Acad Sci; 2007 Sep; 1110():402-9. PubMed ID: 17911455
[TBL] [Abstract][Full Text] [Related]
5. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
6. PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice.
Reinhold D; Bank U; Entz D; Goihl A; Stoye D; Wrenger S; Brocke S; Thielitz A; Stefin S; Nordhoff K; Heimburg A; Täger M; Ansorge S
Biol Chem; 2011 Mar; 392(3):233-7. PubMed ID: 21194377
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune disease.
Reinhold D; Hemmer B; Gran B; Steinbrecher A; Brocke S; Kähne T; Wrenger S; Born I; Faust J; Neubert K; Martin R; Ansorge S
Adv Exp Med Biol; 2000; 477():155-60. PubMed ID: 10849742
[TBL] [Abstract][Full Text] [Related]
8. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
J Immunol; 2001 Feb; 166(3):2041-8. PubMed ID: 11160254
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells.
Reinhold D; Bank U; Bühling F; Kähne T; Kunt D; Faust J; Neubert K; Ansorge S
Immunobiology; 1994 Dec; 192(1-2):121-36. PubMed ID: 7750986
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.
Reinhold D; Hemmer B; Gran B; Born I; Faust J; Neubert K; McFarland HF; Martin R; Ansorge S
J Neuroimmunol; 1998 Jul; 87(1-2):203-9. PubMed ID: 9670864
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases.
Kühlmann UC; Chwieralski CE; van den Brule S; Röcken C; Reinhold D; Welte T; Bühling F
Life Sci; 2009 Jan; 84(1-2):1-11. PubMed ID: 18973761
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase IV in inflammatory CNS disease.
Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
Adv Exp Med Biol; 2000; 477():145-53. PubMed ID: 10849741
[TBL] [Abstract][Full Text] [Related]
13. DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis.
Reinhold D; Bank U; Täger M; Ansorge S; Wrenger S; Thielitz A; Lendeckel U; Faust J; Neubert K; Brocke S
Front Biosci; 2008 Jan; 13():2356-63. PubMed ID: 17981717
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Biton A; Bank U; Täger M; Ansorge S; Reinhold D; Lendeckel U; Brocke S
Adv Exp Med Biol; 2006; 575():177-86. PubMed ID: 16700521
[No Abstract] [Full Text] [Related]
15. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation.
Thielitz A; Reinhold D; Vetter R; Bank U; Helmuth M; Hartig R; Wrenger S; Wiswedel I; Lendeckel U; Kähne T; Neubert K; Faust J; Zouboulis CC; Ansorge S; Gollnick H
J Invest Dermatol; 2007 May; 127(5):1042-51. PubMed ID: 16778789
[TBL] [Abstract][Full Text] [Related]
16. The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases.
Thielitz A; Ansorge S; Bank U; Tager M; Wrenger S; Gollnick H; Reinhold D
Front Biosci; 2008 Jan; 13():2364-75. PubMed ID: 17981718
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions.
Ansorge S; Bank U; Heimburg A; Helmuth M; Koch G; Tadje J; Lendeckel U; Wolke C; Neubert K; Faust J; Fuchs P; Reinhold D; Thielitz A; Täger M
Clin Chem Lab Med; 2009; 47(3):253-61. PubMed ID: 19327105
[TBL] [Abstract][Full Text] [Related]
18. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26.
Preller V; Gerber A; Wrenger S; Togni M; Marguet D; Tadje J; Lendeckel U; Röcken C; Faust J; Neubert K; Schraven B; Martin R; Ansorge S; Brocke S; Reinhold D
J Immunol; 2007 Apr; 178(7):4632-40. PubMed ID: 17372022
[TBL] [Abstract][Full Text] [Related]
20. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
Fujihashi K; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1993 Dec; 151(12):6681-91. PubMed ID: 7903096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
